Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer

Clinical trial NCT01196429 · COMPLETED

Trial details

NCT number: NCT01196429
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Clear Cell Cystadenocarcinoma Stage III Ovarian Cancer Stage IV Ovarian Cancer

Start date: 2010-08-01
Primary completion: 2015-01-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.